Showing 2 of 2 recruiting trials for “Inherited isolated arrhythmogenic cardiomyopathy, dominant-left variant”
Enrolling by InvitationNCT07050160 ↗
Long-term Follow-up Study of Gene Therapy for Arrhythmogenic Cardiomyopathy Due to a Plakophilin-2 Pathogenic Variant
Targeted Therapy With Glycogen Synthase Kinase-3 Inhibition for Arrhythmogenic Cardiomyopathy
👨⚕️ Jason D Roberts, MD MAS, McMaster University and Population Health Research Institute📍 17 sites📅 Started Mar 2025View details ↗
Get alerts when new trials open
Create a free account to follow conditions and receive trial notifications.
Create free account →